tltörultctrtitlttc rle lu plulturt lc.s etude.s .sttr lc.s ttttrtolttu'tit'ulc.t ltait cetttt'e .sur l'urrtöliorutirnt rlu trrtitentcttt du glauc'rnle put' lcs puru.st'trtlxttltonrirttäriquc.s et le.s ...
s . T . P .P H A R M AS C T E N C E7S ( 6 \ 4 4 5 - 4 5 11 9 9 7
Acrylic nanoparticlesfor ocular drug delivery K. Langer,A. Zimmer and J. Kreuter* lnstitut für PharmazeutischeTechnologie,Johann-Wolfgang-Goethe-Universrtät, Biozentrum,Niederursel Marie-Curie-Straße9, 60439 Frankfurt-am-Main,Germany *Correspondence
'f
hc c.f]icuct'ololthtltulrrticdru,qdcliyery st:s[emsi.sgovented b)' tlteir ubilitv to ittt'reu.sctlrc ot'ulur rcsitlcncc tinte. Seyerul u t l ( t t r l ) 1 . \t t ' ( r c n t ( r ( l e l o t t t i t t i t t t i : t ' t l t t : t ' r t p i t l u r t d c . r t t ' t t . ; i v e pre(ont(ul lo.s.s of tlrc urtntirti.stet'ettdru,q. [Ja,side .sthe upplicatiott rfi'ct'etlrolt.stt'itlt utt ertltuttt'ed yi.sco.sit.t', oculur in.tert.;rtr .xtfi cotttttr'lIert.se.;, crtIIrtitluIdrug curriars,.suc'lto.t ttutlopurticIes or tutno((tltsule.su.; vrell u.s rtticro.sltltcrc.s,werc evuluttled us
L'c.ff'icucitetla.s.s.t'.stitrte.s tlc dölivrurtceoplttultrtiquatlöpcnd tlc laur uptitudc i prolortgcr le ternlt.sdc re.sitleru't: oculttirc. Plusiaur.s tuttutive.s ottt y'tö .fhite.sl)ottt' dirrtittuer lu perte pröcontIule, rupidc ct irrrportuttte, du prrtrlLtit utltnitti.strö. le.:ittscrt.s Outrc l'utili.sutiotttle t'ollvrc.st-rt'i.sco.;ilittttgtrtarrlöc, les re('l(Ltrs collol'tluu.r,Iels ocnluire.sott le.slarttille.s.toultle.;, que les rturtoltttt'tit'ule.s, ou lc.srrticnt.spltire.;, lc.sttttttoc'ultsules o r t t e t e ö t u l i t ; . s ( t t t u n t q u c . r - \ ' . r / a / / r ct .l r' u r t t r t i t t i . \ t t ' i t t i o t t
oltlülrultrticdelit'ery .n'.r/{,/ir^r. Itt ,qerterul,acrylic ucirltleriytttiye.s Iike1xt|.t'uIk.t'Icyunrtut'rt'Iutc.stuttt1toIt'uIkyIntat|rur'rt'Iute.swereophtultniqtr(. Etr ginäru1, le.sdärivö.sde l'ucidc uct'rliqtte, tt'l.s que le,spolwlk.t'l (.\'(utou(t'.\'ltrtc.s Lt.;t'tl et polrulkt'l nrctlrut'r'ylute.s, .f'rtr tlrc ltreput'rttiort o.f drug cttrrier ytrticlcs in thc .si:c rurrg? ltcnreert 200 urul 500 rtnt.Itt tlta pu.sttltc tlterupeutic goul rfi'tlte trttt.jrtrttrrfi'tlte.sturlie.;vritlt trurtoltttt'ticle.E v,tt.s.foc'u.sed ort tlte intlttot'(nt(ttt o.f tlte gluttcotttu lr(ultnertl tt,sirtg p u t ' u . \ . \ ' n t l t r r t l t o t r r i n t c t i r u' .rst t l l t a t a b l o c k c r s . T h i , s r e y i a t
ortt ötö crnltlora.sl)otu' lu prepurutiott de rectcut'.\purticulilirc.t l'oltjectif tl'tttte tuillc dc 200 ü 500 ttttr. Dttrt.s lc 1tu.s.sö, tltörultctrtitlttcrle lu plulturt lc.s etude.s.sttrlc.sttttrtolttu'tit'ulc.t ltait cetttt'e.surl'urrtöliorutirntrlu trrtitentctttdu glauc'rnle put'
.stttttntrtri:t'.t lh( pr(.ecttt.\tut( of lltt 1tt'1'1t11r'ttlitttt tttetlnrl.so.f ttct'.t'licttuttoptrrliclesutul tlrcir upplicutiott irt .severulirt vitrr'r
lcs puru.st'trtlxttltonrirttäriquc.s et le.sb0tu-bloquurtts.Cetta revrte rö.;tttrrel'ctttt uctttelde.stnötltotlcsde pry'purtttiort des purricule.s
trtttl tn vi\'o .r.\'.rrcll,r. Mrtreoyer. tltc pltanttucokinetic ttrttl pIturtttrtt'rstltttutrtit'efJ'ecIs uf|er ||rc uppIicatirnt rt.f'tlrug-Ioocled ttttttopurtit'les lrt rubbit (,\'e.t $erc cttntlturcd Io convetltiotrul
ucrrlitlttt,s et lt'ttr.r upltlicutiort.s dutt.s tlillercttt.s ^r'.\'.s/änlr,.l in ('l vivo r,/ irt vitro. De plu.s, le.scffct.s ltlturrrtttt'rtrlrttttrttitlrt('\ ttuttolturli f9 9 c / cA ' . f i e r t o p i c a l a p p l i c a t i o nt o a l b i n c r r a b b i t s .t h e r H - p r o g e s t e r o n ce o n c el l t r a t i o n su ' e r ed e t e r n r i n e ci rl r variottsocular tissues.slrchas the cclrnea.aqueoLlslrurnourancl
p r o p e r t i e so f ' t h e d r r - r g H . y c l r o p h o b i cc l r u g s .s u c h a s s t c r o i d s . c x h i b i t a h i g h d r u g l o a d i r r ge f t ' i c i c n c 1t h, a t n r a vi e u c tl o c l e c r e u scel b i o a v a i l a b i l i t yo f t h e d r u g a f t e ra p p l i c a t i o nc. l u ct o t h e r e s L r l t i n g r e c l u c t i o ni n r c l e a s e d u r i n g t h e s h o r t p r e c o n r c a l r c s i c l c n c c p c r i o d . O n t h e o t h e r h a n c l .r ' c 1 1 h ' ydrophilic tlruss nlilv llot
c o r r . j u n c t i v aT. h e t i s s u e c o n c e n t r a t i o n sf o l l o r v i n g t o p i c a l a c l m i n i s t r a t i o no f n a n o p a r t i c l e sw , e r eg e n e r a l l v l b L r r t o l - i v e t i m e s l o w e r t h a n t h a t o b t a i n e dw i t h t h e c o n t r o l s o l u t i o n .I t w a s a s s u n t e dt h a t .c l u et o t h e e x t r er n e l yh i g h a f f i n i t y o t - p r o g e s t e r o n e t i r r t l i c t t a r t o p a r t i c l e st h, e d r u g r v u sl e s sa v a i l a b l ef i t r a b s t l r p t i o r r than irt sillution forrn over the short precornealrcsidence periocl.
a c l s o r b t o t h c s L r r l a c co' f ' t h e p o l y n r e r -r r r a t c r i i r l s .F - o r r o n i e h y d r o p h i l i c d r u g s . n e w c o p o l y n r e r s l i r r t h e l ) r c p a r a t i o l to l n a n o p a r t i c l e st h a t b i n d t h e c l r u s sb y i o n i c i n t e r r c t i o n u r e L r n d e r i n v e s t i - e a t i < l nC. ) p t i r r i a ll o i t c l i n ec o n d i t i o n s o l ' p o l v a c r y l i c
In a recentstudy,copcllyrnernanoparticleswere investigtrted
n a n o p a r t i c l e ss h o w e d a s i g n i f i c a n te n h a n c : e n rne[ i n t h e o c u l a r
449
S . T . P . P H A R M A S C I E N C E S 7 ( 6 ) 4 4 5 - 4 5 11 9 9 7
Acrylic nanoparticles for ocular drug delivery K. Lanoer. A. Zimmer and J Kreuter
b i o a v a i l a b i l i t yo f d r u - u sc o m p a r e dt o c o n v e n t i o n a la q u e o u se y e d r o p p r ep a r a t i o n sb e c a u s eo f a p r o k l n g e d p r e c r t r n c a rl es i d en c c t i r n c o f t h e p a r t i c u l a t ec a r r i c r s .I t w a s s h o w n t l r a tn a n o p a r t i c l es adhere pref'erentiallyto inflanted tissues. Thcreforc.
1B
n a n o p a r t i c l c sm a y h o l d p r o r n i s ef i r r t h e t h er a p y o f i n f l a n r n u l t o r y D r e c o r n e i ldl i s e a s e - .
19
REFERENCES
20
1.
2.
3.
4.
5.
6.
7.
B.
9.
10.
1'1.
12.
14.
15.
16.
17.
P A T T O NT . F a n d R O B I N S O NJ . R .- Q u a n t i t a t i vper e c o r n e a l dispositionof topicallyapplied pilocarpinenitrate in rabbit zl e y e s .- J . P h a r mS . c i . , 6 51 , 2 9 5 - 1 3 0 1 ,9 7 6 . LEEV H.LandROBINSONJ.R.-Mechanisticandquantitatrve evaluation of precornealpilocarpine inalbinorabbrts. disposition zz. J. Pharm"Sci , 68, 322-333,1979. KREUTERJ. - Particulates (nanoparticles andmicropartrcles). I n : O p h t h a l m idcr u gd e l i v e r ys y s t e m sA, . K . M i t r aE d . ,M a r c e l Dekker,New York,1993,pp. 275-285. P E P P A SN . A .a n dB U R IP . A .- S u r f a c ei n. t e r f a c i a l a n mdo l e c u l a r aspectsof polymerbioadhesion on softtissues.- J. Controlled t+. R e l . ,2 5 7 - 2 7 51, 9 8 5 . PIMIENTC A .,LENAERTS V . , C A D I E U XC . , R A Y M O N DP . , J U H A S ZJ . ,S I M A R DM . A .a n dJ O L I C E U R C .- M u c o a d h e s i o n of hydroxypropyl methacrylate nanoparticles to intestinalileal 25. segmentsin vitro.- Pharm.Res.,7, 49 - 53. 1990. U N L ÜN . , L U D W I GA . , V A N O O T E G H E MM , A N dH I N C A L A . A .- F o r m u l a t i oonf C a r b o p o l 9 4oOp h t h a l m ivce h i c l e sa,n di n vitroevaluation of the influenceof stimulatedlacrimalfluidon properties.- Pharmazie,46, 784-788, their physicochemical 1991. G U R N YR , , I B R A H I MH . , A E B IA . , B U R IP . , W I L S O NC . G , , 27. W A S H I N G T O N . , E D M A NP . a n dC A M B E RO . - D e s i g na n d evaluationof controlledreleasesvstemsfor the eve. - J. C o n t r o l l eR d e l . ,3 6 7 - 3 7 3 1, 9 8 7 . K R E U T E RJ - N a n o p a r t i c l e s- . I n : E n c y c l o p e d i oa f P h a r m a c e u t i c a l T e c h n o lJo.gSy.B , o y l a na n dJ . C .B o y l a nE d s . , M a r c eD l e k k e rN , e w Y o r k ,1 9 9 a ,p p . 1 6 5 - 1 9 0 . KREUTER J . a n dZ E H N D E RH . J .- T h eu s eo f 6 0 O o - y - i r r a d i a t i o n fortheproduetion of vaccines.- Radiation Effects,35, 161-166, 1978. 30. B E R GU E . , K R E U T E RJ . , S P E I S E RP . P a n d S O L V I AM . Herstellung undIn-vitroPrüfungvon polymerenAdjuvantien für l m p f s t o f f e- .P h a r m .I n d . , 4 8 ,7 5 - 7 9 ,1 9 8 6 . 31. R O L L A N DA " ,G I B A S S I E R D . , S A D OP . a n d L E V E R G ER . Möthodologie de prdparation de vecteursnanoparticulaires ä s c r y l i q u e s- .J . P h a r m .B e l g . ,4 1 , 8 3 - 9 3 , b a s ed e p o l y m ö r e a 1986 32. KREUTER J " ,L I E H LE . ,B E R GU . ,S O L V I AM . a n dS P E I S E R P.P. Influenceof hydrophobicity on the adjuvanteffectof particulate polymericadjuvants.- Vaccine,6, 253-256,1988. Z O S E L8 . ,K U N Z EH .a n dD I T T G E N M .- E i n f l u d ß e rl o n e n s t ä r k e - Pharmazie, auf das Zetapotential von Polyacrylatlatices. 43, JJ. 6s3-654,1988. D I T T G E NM a n d Z O S E L B . l n f l u e n c eo f v a l e n c ea n d concentration of electrolytes on thezetapotential of polyacrylic l a t t i c e s-.C o l l o i dP o l y m .S c i . ,2 6 9 ,2 5 9 - 2 6 3.,1 9 9 1 . L U K O W S KGI . .M Ü L L E RR . H . .M Ü L L E RB . W .A N dD I T T G E N M. - Acrylicacid copolymernanoparlicles for drugdelivery.| : 34 Characterization of the surfacepropertiesrelevantlor in vivo o r g a nd i s t r i b u t i o-nI.n t .J . P h a r m .8, 4 , 2 3 - 3 1, 1 9 9 2 . L A N G E RK . ,M A R B U R G E C R . ,B E R T H O L D A . ,K R E U T E R J. a n d S T I E N E K E RF . - M e t h y l m e t h a c r y l a t se u l f o p r o p y l 35. methacrylate copolymernanoparticles for drug delivery.| :
450
- Int. J. Preparationand physicochemical characterization. P h a r m . 1, 3 7 ,6 7 - 7 4 ,1 9 9 6 . W O O DR . W . ,L l V . H . K . ,K R E U T E R J . a n dR O B I N S O N J . R .p o l y h e x y l 2 c y a n o [ 3 ' ' C ] a c r ylate O c u l a r d i s p o s i t i o no f , 3, 175-183, n a n o p a r t i c l ei ns a l b i n or a b b i t s-. I n t .J . P h a r m . 2 19 8 5 . KREUTER J . - N a n o p a r t i c laessb i o a d h e s i voec u l a r d r udge l i v e r y DrugDeliverySystems,V. Lenaerts systems.- In : Bioadhesive a n d R . G u r n yE d s . ,C R S P r e s s ,B o c a R a t o n ,1 9 9 0 ,p p . 2 0 3 212. F I T Z G E R A LPD. ,H A D G R A F JT. , K R E U T E R J . a n dW I L S O N of microparticulate C.G.- A 7-scintigraphic evaluation ophthalmrc - lsn t .J . P h a r r n . . d e l i v e rsyy s t e m sl:i p o s o m easn dn a n o p a r t i c l e 40, 8'1-84, 1987. rates VEZINW. R. and FLORENCEA.T. - ln vitrodegradation o f b i o d e g r a d a b lpeo l y - n - a l k ycly a n o a c r y l a t e s- . J . P h a r m P h a r m a c o l3. ,0 , 5 P , 1 9 7 8 . VEZIN W.R. and FLORENCEA.T. - ln vitroheterogeneous - J. Bromed. degradationof poly(n-alkylcr.-cyanoacrylates). M a t e rR . e s . ,1 4 ,9 3 - 1 0 61, 9 8 0 . S T E I NM . a n d H A M A C H E RE . - D e g r a d a t i oonf p o l y b u t y2l , 0, R11-R13 c y a n o a c r y l a tme i c r o p a r t i c l e-sI.n t .J . P h a r m . 8 1992. DIEPOLR D . ,K R E U T E R JG. ,U G G E N B U HPL.a n dR O B I N S O N J . R . - D i s t r i b u t i o no f p o l y - h e x y l - 2 - c y a n o [ 3 - 1 4 aC c r]y l a t e nanoparticles in healthyand chronically inflamedrabbiteyes.I n t .J . P h a r m .5, 4 , 1 4 9 - 1 5 31,9 8 9 . ZIMMER A . K .M , A I N C E NP T . ,T H O U V E N OPT.a n dK R E U T E R J. - Hydrocortisone deliveryto healthyand inflamedeyesusing a m i c e l l apr o l y s o r b a tBe0 s o l u t i o no r a l b u m i nn a n o p a r t i c l e-s . l n t .J . P h a r m .1.1 0 . 2 1 1 - 2 2 12 9. 9 4 . ZIMMER 4 . ,K R E U T E R J . a n dR O B I N S O JN. R .- S t u d i eos n t h e transportpathwayof PBCAnanoparticles in oculartissues- J. M i c r o e n c a p s u l a t i8o,n4,9 7 - 5 0 41, 9 9 1 . K A Y EG . l .a n d P A P P A SG . D .- S t u d i e so n t h e c o r n e a |. : T h e fine structureof the rabbitcorneaand the uptakeof colloidal p a r t i c l ebs y t h e c o r n e a-. J . C e l l .B i o l . ,1 2 , 1 5 7 - 1 7 9 , 1 9 6 2 . S I E GJ . W .a n dT R I P L E T T J . W .- P r e c o r n e ar el t e n t i oonf t o p r c a l i n s t i l l e dm i c r o n i z e p d a r t i c l e s-. J . P h a r m .S c i . ,6 9 , 8 6 3 - 8 6 4 1980. H A R M I AT . , S P E I S E RP . a n d K R E U T E RJ . - O p t i m i z a t i oonf pilocarpine loadingontonanoparticles by sorptionprocedures. I n t .J . P h a r m .3, 3 , 4 5 - 5 4 ,1 9 8 6 . H A R M I AT . , S P E I S E RP . a n d K R E U T E RJ . - A s o l i dc o l l o i d a l drugdeliverysystemfor the eye : encapsulation of pilocarpine i n n a n o p a r t i c l e-sJ.. M i c r o e n c a p s u l a t i3o,n3, - 1 2 ,1 9 8 6 . H A R M I AT . ,K R E U T E R J . ,S P E I S E R P , B O Y ET , G U R N YR and KUBISA. - Enhancement of the myoticresponseof rabbits polybutyl withpilocarpine-loaded cyanoacrylate nanoparticles. I n t .J . P h a r m .3, 3 , 1 8 7 - 1 9 31,9 8 6 . HARMIA-PULKKINE T .N,T U O M IA . a n dK R I S T O F F E R S S O N E. - Manufacture of polyalkylcyanoacrylate nanoparticles with pilocarpineand timolol by micellepolymerization: factors - J. Microencapsulation, particle influencing formation. 6. 87-93, 19 8 9 . D I E P O L DR . , K R E U T E RJ , H I M B E RJ . , G U R N Y R . , L E E V . H . L .R, O B I N S O N J . RS.A, E T T O N M E . F .a n dS C H N A U D I c E L O.E.- Comparison modelsforthetestingof pilocarpine ofdifferent eyedropsusing conventionaleyedropsand a novel depol f o r m u l a t i o n( n a n o p a r t i c l e s ) .G r a e f e ' sA r c h . C l i n . E x p Ophthalmol., 227, 1BB-'1 93. 1989. Z I M M E R4 . , M U T S C H L E R E . ,L A M B R E C HG T , , M A Y E RD . a n d K R E U T E RJ . - P h a r m a c o k i n e a t i nc d p h a r m a c o d y n a m i c aspectsof an ophthalmicpilocarpinenanoparticledelivery s y s t e m-. P h a r mR . e s . ,1 1 ,1 4 3 5 - 1 4 4 2 , 1 9 9 4 . MARCHAL-HEUSSLE 1 .R. M A I N C E N TP . . H O F F M A NM " . SPITTLER J . a n d C O U V R E U RP . - A n t i o l a u c o m a t oaucst i v i t v
s . T . P .P H A R M AS C T E N C E7S( 6 \ 4 4 5 - 4 5 11 9 9 7
Acrylic nanoparticles for ocular drug delivery K. Langer, A. Zimmer and J. Kreuter
36.
37
o f b e t a x o l o lc h l o r h y d r a t es o r b e d o n t o d i f f e r e n ti s o b u t y - Int.J. Pharm.,58, preparations. nanoparticle cyanoacrylate 11 5 - 1 2 21,9 9 0 . MARCHAL-HEUSSLE 1 ,R, F E S S IH , , D E V I S S A G U EJT. P . , HOFFMA.N M . a n d M A I N C E N TP . - C o l l o i d adl r u g d e l i v e r y systemsfor the eye. A comparisonof the efficacyof three differentpolymers: polisobutylcyanoacrylate, polylactic-cog l y c o l ia c c i d ,p o l y - -ec a p r o l a c t o n-eS. . T . P P . h a r m aS c i . ,2 , 9 8 1 0 5 ,1 9 9 2 . A I - K H O U R IN . , R O B L O T - T R E U P E 1L . , F E S S I H . , DEVISSAGUETJa . Pn.dP U I S I E U F X.- D e v e l o p m e n taonf e w processfor the manufactureof polyisobutylcyanoacrylate n a n o c a p s u l e-sl.n t .J . P h a r m a c o l2. ,8 , 1 2 5 - 1 3 21, 9 8 5 . L O S AC . ,M A R C H A L - H E U S S L E 1R , ,O R A L L OF . ,V I L AJ A T O J . L .a n dA L O N S OM . J . - D e s i g no f n e wf o r m u l a t i o nf os rt o p i c a l o c u l a ra d m i n i s t r a t r o: np o l y m e r i cn a n o c a p s u l ecso n t a i n i n g m e t i p r a n o l o- lP . h a r m .R e s . .1 0 .B 0 - 8 7 1. 9 9 3 .
451
40.
^.1 at-
42.
L O S A C .C, A L V OP . ,C A S T R OE . ,V I L A - J A T O J .aLn. d A L O N S O M.J.- lmprovement of ocularpenetration of amikacinsulphate - J. to polybutylcyanoacrylate nanoparticles. by association P h a r m .P h a r m a c o l4. ,3 , 5 4 8 - 5 5 21, 9 9 1 . , O O D R . W . ,K R E U T E RJ . , H A R M I AT . a n d Ll V.H.K.W ROBINSON J . R .- O c u l a rd r u gd e l i v e r o y f p r o g e s t e r o nues i n g n a n o p a r t i c l e-sJ. . M i c r o e n c a p s u l a t i3o,n2, 1 3 - 2 1 81, 9 8 6 . L A N G E RK . - E n t w i c k l u nugn d C h a r a k t e r i s i e r uknogl l o i d a l e r S y s t e m e a l s T r ä g e r f ü r M u s c a r i n r e z e p t o r - A g o n i s tzeunr A n w e n d u n ag m A u g e .- V e r l a gS h a k e rA , a c h e n ,1 9 9 7 . Z I M M E RA . K . C , H E T O NPI . ,S A E T T O N M , E R B EH . a n d E . F .Z KREUTER of pilocarpine-loaded albuminparticles J. - Evaluation a s c o n t r o l l e dd r u g d e l i v e r ys y s t e m sf o r t h e e y e . l l : C o a d m i n i s t r a t i owni t h b i o a d h e s i v ae n d v i s c o u sp o l y m e r s -. J C o n t r o l l eR d e l . .3 3 . 3 1- 4 6 . 1 9 9 5 .
